Global Intravenous Immunoglobulin (IVIg) Market Research Report 2020

Global Intravenous Immunoglobulin (IVIg) Market Research Report 2020

Table of Contents
1 Intravenous Immunoglobulin (IVIg) Market Overview
1.1 Product Overview and Scope of Intravenous Immunoglobulin (IVIg)
1.2 Intravenous Immunoglobulin (IVIg) Segment by Type
1.2.1 Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 IVIg Liquid
1.2.3 IVIg Powder
1.3 Intravenous Immunoglobulin (IVIg) Segment by Application
1.3.1 Intravenous Immunoglobulin (IVIg) Sales Comparison by Application: 2020 VS 2026
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Intravenous Immunoglobulin (IVIg) Market Size Estimates and Forecasts
1.4.1 Global Intravenous Immunoglobulin (IVIg) Revenue 2015-2026
1.4.2 Global Intravenous Immunoglobulin (IVIg) Sales 2015-2026
1.4.3 Intravenous Immunoglobulin (IVIg) Market Size by Region: 2020 Versus 2026
2 Global Intravenous Immunoglobulin (IVIg) Market Competition by Manufacturers
2.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Manufacturers (2015-2020)
2.2 Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers (2015-2020)
2.3 Global Intravenous Immunoglobulin (IVIg) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Intravenous Immunoglobulin (IVIg) Manufacturing Sites, Area Served, Product Type
2.5 Intravenous Immunoglobulin (IVIg) Market Competitive Situation and Trends
2.5.1 Intravenous Immunoglobulin (IVIg) Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Intravenous Immunoglobulin (IVIg) Players (Opinion Leaders)
3 Intravenous Immunoglobulin (IVIg) Retrospective Market Scenario by Region
3.1 Global Intravenous Immunoglobulin (IVIg) Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Intravenous Immunoglobulin (IVIg) Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.3.1 North America Intravenous Immunoglobulin (IVIg) Sales by Country
3.3.2 North America Intravenous Immunoglobulin (IVIg) Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.4.1 Europe Intravenous Immunoglobulin (IVIg) Sales by Country
3.4.2 Europe Intravenous Immunoglobulin (IVIg) Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Region
3.5.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region
3.5.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.6.1 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country
3.6.2 Latin America Intravenous Immunoglobulin (IVIg) Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Intravenous Immunoglobulin (IVIg) Market Facts & Figures by Country
3.7.1 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country
3.7.2 Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Intravenous Immunoglobulin (IVIg) Historic Market Analysis by Type
4.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type (2015-2020)
4.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Type (2015-2020)
4.3 Global Intravenous Immunoglobulin (IVIg) Price Market Share by Type (2015-2020)
4.4 Global Intravenous Immunoglobulin (IVIg) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Intravenous Immunoglobulin (IVIg) Historic Market Analysis by Application
5.1 Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
5.2 Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Application (2015-2020)
5.3 Global Intravenous Immunoglobulin (IVIg) Price by Application (2015-2020)
6 Company Profiles and Key Figures in Intravenous Immunoglobulin (IVIg) Business
6.1 Baxter
6.1.1 Corporation Information
6.1.2 Baxter Description, Business Overview and Total Revenue
6.1.3 Baxter Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Baxter Products Offered
6.1.5 Baxter Recent Development
6.2 Grifols
6.2.1 Grifols Intravenous Immunoglobulin (IVIg) Production Sites and Area Served
6.2.2 Grifols Description, Business Overview and Total Revenue
6.2.3 Grifols Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Grifols Products Offered
6.2.5 Grifols Recent Development
6.3 CSL
6.3.1 CSL Intravenous Immunoglobulin (IVIg) Production Sites and Area Served
6.3.2 CSL Description, Business Overview and Total Revenue
6.3.3 CSL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
6.3.4 CSL Products Offered
6.3.5 CSL Recent Development
6.4 Octapharma
6.4.1 Octapharma Intravenous Immunoglobulin (IVIg) Production Sites and Area Served
6.4.2 Octapharma Description, Business Overview and Total Revenue
6.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Octapharma Products Offered
6.4.5 Octapharma Recent Development
6.5 Biotest
6.5.1 Biotest Intravenous Immunoglobulin (IVIg) Production Sites and Area Served
6.5.2 Biotest Description, Business Overview and Total Revenue
6.5.3 Biotest Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Biotest Products Offered
6.5.5 Biotest Recent Development
6.6 Kedrion
6.6.1 Kedrion Intravenous Immunoglobulin (IVIg) Production Sites and Area Served
6.6.2 Kedrion Description, Business Overview and Total Revenue
6.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Kedrion Products Offered
6.6.5 Kedrion Recent Development
6.7 Hualan Bio
6.6.1 Hualan Bio Intravenous Immunoglobulin (IVIg) Production Sites and Area Served
6.6.2 Hualan Bio Description, Business Overview and Total Revenue
6.6.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Hualan Bio Products Offered
6.7.5 Hualan Bio Recent Development
6.8 CNBG
6.8.1 CNBG Intravenous Immunoglobulin (IVIg) Production Sites and Area Served
6.8.2 CNBG Description, Business Overview and Total Revenue
6.8.3 CNBG Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
6.8.4 CNBG Products Offered
6.8.5 CNBG Recent Development
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Production Sites and Area Served
6.9.2 Shanghai RAAS Description, Business Overview and Total Revenue
6.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Shanghai RAAS Products Offered
6.9.5 Shanghai RAAS Recent Development
6.10 CBPO
6.10.1 CBPO Intravenous Immunoglobulin (IVIg) Production Sites and Area Served
6.10.2 CBPO Description, Business Overview and Total Revenue
6.10.3 CBPO Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
6.10.4 CBPO Products Offered
6.10.5 CBPO Recent Development
6.11 LFB Group
6.11.1 LFB Group Intravenous Immunoglobulin (IVIg) Production Sites and Area Served
6.11.2 LFB Group Intravenous Immunoglobulin (IVIg) Description, Business Overview and Total Revenue
6.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
6.11.4 LFB Group Products Offered
6.11.5 LFB Group Recent Development
6.12 BPL
6.12.1 BPL Intravenous Immunoglobulin (IVIg) Production Sites and Area Served
6.12.2 BPL Intravenous Immunoglobulin (IVIg) Description, Business Overview and Total Revenue
6.12.3 BPL Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
6.12.4 BPL Products Offered
6.12.5 BPL Recent Development
6.13 Sichuan Yuanda Shuyang
6.13.1 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Production Sites and Area Served
6.13.2 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Description, Business Overview and Total Revenue
6.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales, Revenue and Gross Margin (2015-2020)
6.13.4 Sichuan Yuanda Shuyang Products Offered
6.13.5 Sichuan Yuanda Shuyang Recent Development
7 Intravenous Immunoglobulin (IVIg) Manufacturing Cost Analysis
7.1 Intravenous Immunoglobulin (IVIg) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
7.4 Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Intravenous Immunoglobulin (IVIg) Distributors List
8.3 Intravenous Immunoglobulin (IVIg) Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Intravenous Immunoglobulin (IVIg) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Intravenous Immunoglobulin (IVIg) by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Intravenous Immunoglobulin (IVIg) by Type (2021-2026)
10.2 Intravenous Immunoglobulin (IVIg) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Intravenous Immunoglobulin (IVIg) by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Intravenous Immunoglobulin (IVIg) by Application (2021-2026)
10.3 Intravenous Immunoglobulin (IVIg) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Intravenous Immunoglobulin (IVIg) by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Intravenous Immunoglobulin (IVIg) by Region (2021-2026)
10.4 North America Intravenous Immunoglobulin (IVIg) Estimates and Projections (2021-2026)
10.5 Europe Intravenous Immunoglobulin (IVIg) Estimates and Projections (2021-2026)
10.6 Asia Pacific Intravenous Immunoglobulin (IVIg) Estimates and Projections (2021-2026)
10.7 Latin America Intravenous Immunoglobulin (IVIg) Estimates and Projections (2021-2026)
10.8 Middle East and Africa Intravenous Immunoglobulin (IVIg) Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Comparison by Application: 2020 VS 2026
Table 3. Global Intravenous Immunoglobulin (IVIg) Market Size by Type (K Bottle) (US$ Million) (2020 VS 2026)
Table 4. Global Key Intravenous Immunoglobulin (IVIg) Manufacturers Covered in This Study
Table 5. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Manufacturers (2015-2020)
Table 6. Global Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturers (2015-2020)
Table 7. Global Intravenous Immunoglobulin (IVIg) Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Intravenous Immunoglobulin (IVIg) Average Price (USD/Bottle) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Intravenous Immunoglobulin (IVIg) Sales Sites and Area Served
Table 11. Manufacturers Intravenous Immunoglobulin (IVIg) Product Types
Table 12. Global Intravenous Immunoglobulin (IVIg) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Intravenous Immunoglobulin (IVIg) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Immunoglobulin (IVIg) as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Intravenous Immunoglobulin (IVIg) Players
Table 16. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Region (2015-2020)
Table 17. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2015-2020)
Table 18. Global Intravenous Immunoglobulin (IVIg) Revenue (Million US$) by Region (2015-2020)
Table 19. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2015-2020)
Table 20. North America Intravenous Immunoglobulin (IVIg) Sales by Country (2015-2020) (K Bottle)
Table 21. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2015-2020)
Table 22. North America Intravenous Immunoglobulin (IVIg) Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2015-2020)
Table 24. Europe Intravenous Immunoglobulin (IVIg) Sales by Country (2015-2020) (K Bottle)
Table 25. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2015-2020)
Table 26. Europe Intravenous Immunoglobulin (IVIg) Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales by Region (2015-2020) (K Bottle)
Table 29. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2015-2020)
Table 32. Latin America Intravenous Immunoglobulin (IVIg) Sales by Country (2015-2020) (K Bottle)
Table 33. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2015-2020)
Table 34. Latin America Intravenous Immunoglobulin (IVIg) Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales by Country (2015-2020) (K Bottle)
Table 37. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country (2015-2020)
Table 40. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Type (2015-2020)
Table 41. Global Intravenous Immunoglobulin (IVIg) Sales Share by Type (2015-2020)
Table 42. Global Intravenous Immunoglobulin (IVIg) Revenue (Million US$) by Type (2015-2020)
Table 43. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Type (2015-2020)
Table 44. Global Intravenous Immunoglobulin (IVIg) Price (USD/Bottle) by Type (2015-2020)
Table 45. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) by Application (2015-2020)
Table 46. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
Table 47. Global Intravenous Immunoglobulin (IVIg) Sales Growth Rate by Application (2015-2020)
Table 48. Baxter Intravenous Immunoglobulin (IVIg) Corporation Information
Table 49. Baxter Description and Business Overview
Table 50. Baxter Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 51. Baxter Main Product
Table 52. Baxter Recent Development
Table 53. Grifols Intravenous Immunoglobulin (IVIg) Corporation Information
Table 54. Grifols Corporation Information
Table 55. Grifols Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 56. Grifols Main Product
Table 57. Grifols Recent Development
Table 58. CSL Intravenous Immunoglobulin (IVIg) Corporation Information
Table 59. CSL Corporation Information
Table 60. CSL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 61. CSL Main Product
Table 62. CSL Recent Development
Table 63. Octapharma Intravenous Immunoglobulin (IVIg) Corporation Information
Table 64. Octapharma Corporation Information
Table 65. Octapharma Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 66. Octapharma Main Product
Table 67. Octapharma Recent Development
Table 68. Biotest Intravenous Immunoglobulin (IVIg) Corporation Information
Table 69. Biotest Corporation Information
Table 70. Biotest Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 71. Biotest Main Product
Table 72. Biotest Recent Development
Table 73. Kedrion Intravenous Immunoglobulin (IVIg) Corporation Information
Table 74. Kedrion Corporation Information
Table 75. Kedrion Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 76. Kedrion Main Product
Table 77. Kedrion Recent Development
Table 78. Hualan Bio Intravenous Immunoglobulin (IVIg) Corporation Information
Table 79. Hualan Bio Corporation Information
Table 80. Hualan Bio Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 81. Hualan Bio Main Product
Table 82. Hualan Bio Recent Development
Table 83. CNBG Intravenous Immunoglobulin (IVIg) Corporation Information
Table 84. CNBG Corporation Information
Table 85. CNBG Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 86. CNBG Main Product
Table 87. CNBG Recent Development
Table 88. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Corporation Information
Table 89. Shanghai RAAS Corporation Information
Table 90. Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 91. Shanghai RAAS Main Product
Table 92. Shanghai RAAS Recent Development
Table 93. CBPO Intravenous Immunoglobulin (IVIg) Corporation Information
Table 94. CBPO Corporation Information
Table 95. CBPO Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 96. CBPO Main Product
Table 97. CBPO Recent Development
Table 98. LFB Group Intravenous Immunoglobulin (IVIg) Corporation Information
Table 99. LFB Group Corporation Information
Table 100. LFB Group Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 101. LFB Group Main Product
Table 102. LFB Group Recent Development
Table 103. BPL Intravenous Immunoglobulin (IVIg) Corporation Information
Table 104. BPL Corporation Information
Table 105. BPL Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 106. BPL Main Product
Table 107. BPL Recent Development
Table 108. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Corporation Information
Table 109. Sichuan Yuanda Shuyang Corporation Information
Table 110. Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales (K Bottle), Revenue (Million US$), Price (USD/Bottle) and Gross Margin (2015-2020)
Table 111. Sichuan Yuanda Shuyang Main Product
Table 112. Sichuan Yuanda Shuyang Recent Development
Table 113. Sales Base and Market Concentration Rate of Raw Material
Table 114. Key Suppliers of Raw Materials
Table 115. Intravenous Immunoglobulin (IVIg) Distributors List
Table 116. Intravenous Immunoglobulin (IVIg) Customers List
Table 117. Market Key Trends
Table 118. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 119. Key Challenges
Table 120. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Forecast by Type (2021-2026)
Table 121. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Type (2021-2026)
Table 122. Global Intravenous Immunoglobulin (IVIg) Revenue (Million US$) Forecast by Type (2021-2026)
Table 123. Global Intravenous Immunoglobulin (IVIg) Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 124. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Forecast by Application (2021-2026)
Table 125. Global Intravenous Immunoglobulin (IVIg) Revenue (Million US$) Forecast by Application (2021-2026)
Table 126. Global Intravenous Immunoglobulin (IVIg) Sales (K Bottle) Forecast by Region (2021-2026)
Table 127. Global Intravenous Immunoglobulin (IVIg) Sales Market Share Forecast by Region (2021-2026)
Table 128. Global Intravenous Immunoglobulin (IVIg) Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share Forecast by Region (2021-2026)
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Intravenous Immunoglobulin (IVIg)
Figure 2. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Type: 2020 VS 2026
Figure 3. IVIg Liquid Product Picture
Figure 4. IVIg Powder Product Picture
Figure 5. Global Intravenous Immunoglobulin (IVIg) Consumption Market Share by Application: 2020 VS 2026
Figure 6. Immunodeficiency
Figure 7. Autoimmune Disease
Figure 8. Acute Infection
Figure 9. Global Intravenous Immunoglobulin (IVIg) Market Size 2015-2026 (US$ Million)
Figure 10. Global Intravenous Immunoglobulin (IVIg) Sales Capacity (K Bottle) (2015-2026)
Figure 11. Global Intravenous Immunoglobulin (IVIg) Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Intravenous Immunoglobulin (IVIg) Sales Share by Manufacturers in 2020
Figure 13. Global Intravenous Immunoglobulin (IVIg) Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Intravenous Immunoglobulin (IVIg) Revenue in 2019
Figure 15. Intravenous Immunoglobulin (IVIg) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region (2015-2020)
Figure 17. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Region in 2019
Figure 18. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region (2015-2020)
Figure 19. Global Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region in 2019
Figure 20. North America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2019
Figure 21. North America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country in 2019
Figure 22. U.S. Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 23. U.S. Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 25. Canada Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2019
Figure 27. Europe Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country in 2019
Figure 28. Germany Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 29. Germany Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 31. France Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 33. U.K. Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 35. Italy Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 37. Russia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales Market Share by Region in 2019
Figure 39. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue Market Share by Region in 2019
Figure 40. China Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 41. China Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 43. Japan Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 45. South Korea Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 47. India Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 49. Australia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 51. Taiwan Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 53. Indonesia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 55. Thailand Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 57. Malaysia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 59. Philippines Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 61. Vietnam Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2019
Figure 63. Latin America Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country in 2019
Figure 64. Mexico Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 65. Mexico Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 67. Brazil Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 69. Argentina Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue Market Share by Country in 2019
Figure 72. Turkey Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 73. Turkey Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 75. Saudi Arabia Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Intravenous Immunoglobulin (IVIg) Sales Growth Rate (2015-2020) (K Bottle)
Figure 77. U.A.E Intravenous Immunoglobulin (IVIg) Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Intravenous Immunoglobulin (IVIg) by Type (2015-2020)
Figure 79. Sales Market Share of Intravenous Immunoglobulin (IVIg) by Type in 2019
Figure 80. Revenue Share of Intravenous Immunoglobulin (IVIg) by Type (2015-2020)
Figure 81. Revenue Market Share of Intravenous Immunoglobulin (IVIg) by Type in 2019
Figure 82. Global Intravenous Immunoglobulin (IVIg) Sales Growth by Type (2015-2020) (K Bottle)
Figure 83. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application (2015-2020)
Figure 84. Global Intravenous Immunoglobulin (IVIg) Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Intravenous Immunoglobulin (IVIg) by Application (2015-2020)
Figure 86. Global Revenue Share of Intravenous Immunoglobulin (IVIg) by Application in 2020
Figure 87. Baxter Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Octapharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Biotest Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Kedrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Hualan Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. CNBG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Shanghai RAAS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. CBPO Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. LFB Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. BPL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Sichuan Yuanda Shuyang Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Price Trend of Key Raw Materials
Figure 101. Manufacturing Cost Structure of Intravenous Immunoglobulin (IVIg)
Figure 102. Manufacturing Process Analysis of Intravenous Immunoglobulin (IVIg)
Figure 103. Intravenous Immunoglobulin (IVIg) Industrial Chain Analysis
Figure 104. Channels of Distribution
Figure 105. Distributors Profiles
Figure 106. Porter's Five Forces Analysis
Figure 107. North America Intravenous Immunoglobulin (IVIg) Sales (K Bottle) and Growth Rate Forecast (2021-2026)
Figure 108. North America Intravenous Immunoglobulin (IVIg) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Intravenous Immunoglobulin (IVIg) Sales (K Bottle) and Growth Rate Forecast (2021-2026)
Figure 110. Europe Intravenous Immunoglobulin (IVIg) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Intravenous Immunoglobulin (IVIg) Sales (K Bottle) and Growth Rate Forecast (2021-2026)
Figure 112. Latin America Intravenous Immunoglobulin (IVIg) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Intravenous Immunoglobulin (IVIg) Sales (K Bottle) and Growth Rate Forecast (2021-2026)
Figure 114. Middle East and Africa Intravenous Immunoglobulin (IVIg) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Intravenous Immunoglobulin (IVIg) Sales (K Bottle) and Growth Rate Forecast (2021-2026)
Figure 116. Asia Pacific Intravenous Immunoglobulin (IVIg) Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Bottom-up and Top-down Approaches for This Report
Figure 118. Data Triangulation
Figure 119. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Fibrinogen Concentrate Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 84

The Fibrinogen Concentrate market covers Human Fibrinogen Concentrate, Other, etc. The typical players include CSL Behring, LFB, Shanghai RAAS, Boya, Hualan Biological Engineering, etc. The global Fibrinogen Concentrate market was valued at US$ 796 million in 2023 and is anticipated to reach US$ 2207.6 million by 2030, witnessing a CAGR of 15.5% during The forecast period 2024-2030. The major producers in The industry are CSL Behring, LFB Group and Shanghai RAAS B......

Global Fibrinogen Concentrate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 91

According to our LPI (LP Information) latest study, the global Fibrinogen Concentrate market size was valued at US$ 778.7 million in 2023. With growing demand in downstream market, the Fibrinogen Concentrate is forecast to a readjusted size of US$ 2211.3 million by 2030 with a CAGR of 16.1% during review period. The research report highlights the growth potential of the global Fibrinogen Concentrate market. Fibrinogen Concentrate are expected to show stable growth in the future market. H......

Global Low Molecular Weight Heparin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 124

Market Overview of Global Low Molecular Weight Heparin market: According to our latest research, the global Low Molecular Weight Heparin market looks promising in the next 5 years. As of 2022, the global Low Molecular Weight Heparin market was estimated at USD 359.23 million, and it's anticipated to reach USD 601.59 million in 2028, with a CAGR of 8.97% during the forecast years. Low-molecular-weight heparin (LMWH) is a class of anticoagulant medications. They are used in the......

Global Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 106

According to our LPI (LP Information) latest study, the global Anticoagulants market size was valued at US$ 25390 million in 2023. With growing demand in downstream market, the Anticoagulants is forecast to a readjusted size of US$ 35420 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Anticoagulants market. Anticoagulants are expected to show stable growth in the future market. However, product differentiation, r......

Global Injectable Anticoagulants Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Injectable Anticoagulants market size was valued at US$ 5959.5 million in 2023. With growing demand in downstream market, the Injectable Anticoagulants is forecast to a readjusted size of US$ 6929.9 million by 2030 with a CAGR of 2.2% during review period. The research report highlights the growth potential of the global Injectable Anticoagulants market. Injectable Anticoagulants are expected to show stable growth in the futu......

Global Low Molecular Weight Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 88

According to our LPI (LP Information) latest study, the global Low Molecular Weight Heparin market size was valued at US$ 331.2 million in 2023. With growing demand in downstream market, the Low Molecular Weight Heparin is forecast to a readjusted size of US$ 485.1 million by 2030 with a CAGR of 5.6% during review period. The research report highlights the growth potential of the global Low Molecular Weight Heparin market. Low Molecular Weight Heparin are expected to show stable growth i......

Global Heparin Sodium Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 132

According to our LPI (LP Information) latest study, the global Heparin Sodium market size was valued at US$ 3301.4 million in 2023. With growing demand in downstream market, the Heparin Sodium is forecast to a readjusted size of US$ 5093.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Heparin Sodium market. Heparin Sodium are expected to show stable growth in the future market. However, product differentiation,......

Global Intravenous Immunoglobulin (IVIg) Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120

According to our LPI (LP Information) latest study, the global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 10090 million in 2023. With growing demand in downstream market, the Intravenous Immunoglobulin (IVIg) is forecast to a readjusted size of US$ 15290 million by 2030 with a CAGR of 6.1% during review period. The research report highlights the growth potential of the global Intravenous Immunoglobulin (IVIg) market. Intravenous Immunoglobulin (IVIg) are expected to ......

Global Heparin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128

According to our LPI (LP Information) latest study, the global Heparin market size was valued at US$ 2286.2 million in 2023. With growing demand in downstream market, the Heparin is forecast to a readjusted size of US$ 3831.5 million by 2030 with a CAGR of 7.7% during review period. The research report highlights the growth potential of the global Heparin market. Heparin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs